热门资讯> 正文
Tango Therapeutics获得2.25亿美元融资
2025-10-23 19:33
- Tango Therapeutics (NASDAQ:TNGX) has priced an underwritten offering of 21,023,337 shares of common stock and pre-funded warrants to purchase up to 3,226,458 shares.
- The common stock is priced at $8.66 per share, while each pre-funded warrant is priced at $8.659. The offering is expected to generate approximately $210 million in gross proceeds and is scheduled to close on or around October 24, 2025, subject to customary closing conditions.
- In addition, Tango has entered into a private investment in public equity (PIPE) agreement, selling 1,732,101 shares of common stock at $8.66 per share. The PIPE is expected to bring in approximately $15 million in gross proceeds.
- TNGX +17.7% premarket to $10.19
- Source: Press Release
More on Tango Therapeutics
- Summit draws Neutral view on risk/reward setup as Piper initiates biotech cancer names
- Seeking Alpha’s Quant Rating on Tango Therapeutics
- Historical earnings data for Tango Therapeutics
- Financial information for Tango Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
